Top Institute Pharma (ti Pharma)
LEIDEN, Netherlands, February 23, 2011 - Today, a new initiative, based in the Netherlands, is being launched in
the fight against neglected tropical diseases: The European Solutions
Enterprise for Neglected Diseases (euSEND).
LEIDEN, The Netherlands, February 17, 2011 - Top Institute Pharma (TI Pharma) is today launching a new research
project that should make stem cell transplants more successful.
LEIDEN, The Netherlands, November 17 - Top Institute Pharma (TI Pharma) has formed a
consortium with Actelion Pharmaceuticals Ltd, Erasmus Medical Centre and
Maastricht University to define new modalities for the treatment of
hypertension (high blood pressure) and associated vascular complications such
as heart and kidney failure, myocardial infarction and stroke.
